A equipe de liderança da Accuray está empenhada em possibilitar que os funcionários prosperem, que os clientes se destaquem e que os pacientes tenham uma vida melhor e mais longa. Focamos incansavelmente na inovação em tudo o que fazemos, enquanto nos esforçamos para oferecer oportunidades de crescimento gratificantes por meio de um portfólio altamente diferenciado de tecnologias de radiocirurgia e radioterapia
“Accuray offers the opportunity to collaborate with a dedicated team, deliver exceptional products and services, and partner with radiation oncologists and their multidisciplinary care teams to reduce pain, improve outcomes, and extend patients’ lives.”
Steve La Neve serves as Chief Executive Officer of Accuray, bringing over 40 years of global experience in medical technology and biotechnology, spanning capital equipment and implantable devices. He is recognized for driving operational excellence and delivering sustained value creation.
Prior to Accuray, Steve held several senior executive roles, including President of Globus Medical Japan K.K. and President of Globus Medical Trauma and Joint Reconstruction, a leading musculoskeletal technology company. He also served as Global Sector President for Medtronic’s Spine and Biologics Division. Across these roles, Steve consistently optimized operations, managed costs, achieved financial targets, and expanded revenue streams through innovative technology platforms.
Steve also served as CEO and Board Director of Bone Biologics Corporation, and as President & CEO of ETEX Corporation, where he led the successful sale of the business to a global leader in joint reconstruction. As Global President of Pre-Analytical Systems at Becton Dickinson, he drove revenue and profit growth that outpaced market performance.
Steve holds an MBA from West Chester University and a Bachelor of Science in Health Planning and Administration from Pennsylvania State University. He is a member of Omicron Delta Epsilon, an international honor society recognizing academic excellence and achievements in economics.
Having the ability to impact the lives of patients and their families in a positive way through our innovative radiation therapy technologies is what makes Accuray a very special place to work. Our employees are passionate about our purpose and work hard every day to exceed our customers’ expectations, which makes me really proud to be a part of the team.
Ali Pervaiz was appointed Chief Financial Officer of Accuray in May 2022. In his role as CFO, Ali directs the global finance organization and oversees all aspects of Accuray Incorporated’s finance function. Ali joined Accuray in August 2020 as Vice President, Global Commercial Operations, leading the transformation of the company’s business processes and driving revenue performance. During his 18-year career in the medical technology industry, Ali has established a proven track record for delivering results and creating shareholder value.
Prior to joining Accuray, Ali was with GE Healthcare for over 15 years in senior financial and operating leadership roles. He began his finance career in GE’s prestigious Corporate Audit Staff program, a rigorous multi-year rotation through different divisions used to groom future leaders before assuming increasing levels of responsibility within the Finance organization. Ali previously held the roles of Chief Financial Officer for two GE Healthcare business units including the $1.3B US Imaging Equipment and $650M US Life Support Solutions business.
Ali received a Master of Business Administration degree from the University of Chicago Booth School of Business, a Master of Science in healthcare technologies management from the Medical College of Wisconsin and a Bachelor of Science in electrical engineering from Marquette University.
“Accuray’s unique treatment technologies and patient-centric innovations in radiation therapy either extend or save lives. This creates an amazing opportunity for us to grow globally and build partnerships that result in improved patient care.”
Sandeep Chalke is the Senior Vice President, Chief Commercial Officer at Accuray, bringing more than 25 years of medical device expertise in commercialization, business development and operations. In his role at Accuray Sandeep has responsibility for the global commercial function, including the organization’s sales, service and operations teams.
Prior to joining Accuray, Sandeep was president, Asia-Pacific and Latin America regions at Vyaire Medical, a global respiratory care manufacturer, where he had full P&L responsibility along with oversight of select manufacturing sites. Prior to Vyaire, Sandeep held various global leadership positions at Medtronic, Acelity, Inc. and GE Healthcare, where he led the development of new products and service solutions, established new markets and partnerships with government organizations and private payors to drive revenue growth, margin expansion and technology leadership.
Sandeep earned a Master of Business Administration degree in international marketing from Leicester University, United Kingdom and Medical Electronics Engineering, Bombay University, India.
Leonel Peralta is Senior Vice President, Chief Operations Officer, with overall responsibility for delivering excellence in manufacturing operations. In this role he will drive alignment of operations with corporate business goals, maximize supply chain profitability and efficiency, and ensure processes support best-in-class customer service.
Leonel has a proven work history in driving growth while improving productivity and bringing more than 25 years of leadership experience in supply chain, business process improvement, and manufacturing optimization. Most recently, Leonel was Vice President, Head of Global Operations for the ultrasound division at Siemens Healthineers where he led the transformation of supply chain processes, the manufacturing footprint and the organizational structure, for the ultrasound business unit within the company. Prior to this, Leonel held executive management positions at Medtronic Diabetes, Hill-Rom (Baxter), KCI Medical (3M), and GE Healthcare. Under his leadership his teams executed corporate growth and financial objectives, significantly reduced inventory levels, and transformed sourcing and supply chain operations.
Leonel holds a Master of Business Administration degree in strategy, finance and general management from the University of Chicago Booth School of Business, a Master of Science degree in mechanical engineering with a minor in engineering management from the University of Miami, and a Bachelor of Science degree in mechanical engineering from Florida International University.
Seth Blacksburg is the Senior Vice President, Chief Medical & Marketing Officer at Accuray. In this role he is responsible for leading the organization’s global clinical strategic approach, including customer education, patient access and reimbursement, and clinical research and publication strategy, while bringing the insights and voice of the customer necessary to help drive transformative technological innovations. Dr. Blacksburg also oversees the global marketing and health economics teams, aiming to strengthen strategic positioning, amplify brand outreach, enhance market understanding, and strengthen customer engagement. He additionally holds the title of Adjunct Professor in the Department of Radiation Oncology at the New York University Grossman Long Island School of Medicine, where he continues to provide oncologic care to patients.
Prior to his current role at Accuray, Dr. Blacksburg previously served as the company’s Vice President, Chief Medical Officer for the Americas (North and South America) regions. Before joining Accuray, he was Chairman of Radiation Medicine at Lenox Hill Hospital, a part of Northwell Health, the largest private employer in New York (state). Dr. Blacksburg managed the clinical oversight and strategic development of the department. He also served as a key member of the hospital’s cancer committee, medical board and national accreditation programs for breast and rectal cancers. During Dr. Blacksburg’s tenure with Lenox Hill the cancer program achieved Commission on Cancer accreditation and the department patient volume increased significantly.
Dr. Blacksburg is a board-certified radiation oncologist who earned a master of business administration degree with a concentration in health sector management while concurrently completing his medical studies. He is highly skilled in all facets of radiation oncology, including stereotactic body radiotherapy (SBRT) and radiosurgery for prostate, gastrointestinal, and CNS cancers, and has expertise in the management of breast cancer, brachytherapy, and integrating radiation with immunotherapy. Dr. Blacksburg is considered a thought leader in the field of medical informatics.
“Accuray’s radiation therapy solutions make a real difference in improving patient lives. Its strong, mission-driven culture aligns with my values and makes the work both meaningful and deeply rewarding.”
David Shin, Senior Vice President, Chief Legal Officer & Corporate Secretary, leads the global legal function at Accuray. With more than 20 years of experience across Fortune 100 corporations, private companies, and global law firms, he brings deep expertise in corporate governance, compliance, enterprise risk management, mergers and acquisitions and emerging technologies.
Before joining Accuray, David served as Vice President of Legal – Technology, Transformation & Innovation at HCA Healthcare, where he led the legal strategy for HCA’s AI-driven digital transformation of patient care and operations. Prior to HCA, David served as Chief Legal Officer at private equity- and venture-backed software companies. He also served as Chief Counsel, Chief Privacy Officer and Corporate Secretary to the Ethics & Compliance Committee while at Varian, a Siemens Healthineers company.
David received a Juris Doctor degree from Vanderbilt University Law School and a Bachelor of Arts degree in politics from Occidental College. He is an advisor at Vanderbilt University Law School’s AI Law Lab and a member of the National Association of Corporate Directors.
Jim Dennison is the Senior Vice President, Chief Quality & Regulatory Affairs Officer, bringing more than 20 years of experience in quality assurance and regulatory affairs. In this role, he leads global quality and regulatory/government affairs, along with product compliance. Jim is also responsible for managing the CNNC Accuray China joint venture partnership and its contribution to Accuray business growth.
Prior to joining Accuray, Jim was employed at GE Healthcare, most recently as Senior Executive Vice President, Quality and Regulatory Affairs. Jim’s tenure with GE Healthcare spans nearly 15 years in various executive leadership roles in quality and regulatory affairs, guiding their imaging and overall healthcare businesses. He also has held leadership roles with Medtronic, Mallinckrodt Pharmaceutical and Baxter Healthcare.
Jim earned his Master of Business Administration degree from Keller Graduate School of Management and Bachelor of Science degree in chemistry/biology from the University of Wisconsin.
“Cancer has impacted my family directly over the last 30+ years. It’s an honor for me to work for a company and with a global team that is so committed to developing treatments that can truly help patients live long and fruitful lives.”
Todd Brown is Senior Vice President, Global Commercial Operations and Service bringing more than 25 years of business and finance experience supporting customers and driving growth at start-ups, mid-sized and global enterprises. He is responsible for leading the development and execution of a global strategy to deliver an exceptional customer experience throughout the lifecycle of their relationship with Accuray.
Most recently, Todd was employed at GE HealthCare, where he held multiple leadership positions over his 10+ years tenure, including Vice President & General Manager, Healthcare Service, US & Canada. Todd was responsible for the ~4,700 employee organization, ensuring quality and timely service on over 2 million in assets under contract. Under Todd’s guidance, focused growth programs and cost management, his team delivered both revenue and profit growth in 2020 and in 2021. Before GE Healthcare, Todd held various management positions at ABB Inc., a leader in power and automation technologies and Sani-Matic, Inc., a designer and manufacturer of sanitary cleaning equipment for the Food & Beverage and Pharmaceutical industry.
Todd earned a Bachelor of Business Administration degree, with a double concentration in accounting and management, from the University of Wisconsin, Madison.
John Dunn, as the Senior Vice President, Chief Information Officer at Accuray, oversees the alignment of data strategy, cybersecurity, and services, products, and enterprise-wide portfolio execution to drive operational excellence. He is focused on responsible AI, resilient architecture, and measurable outcomes, empowering teams to make smart decisions faster, de risk change, and innovate with confidence.
Dunn is a forward-thinking, strategic, and collaborative leader with more than 20 years of business intelligence, enterprise technology and cybersecurity experience. Prior to joining Accuray in October 2023, John held roles as the Enterprise CISO and North America CIO of GE Healthcare.
John received a Master of Business Administration degree in Finance, Strategic Management and Entrepreneurship from the University of Chicago Booth School of Business, and a Bachelor’s degree in Electrical & Computer Engineering from Marquette University. John is currently a board member for the National Technology Security Coalition, a non-profit, non-partisan trade association serving as the voice of CISOs to help improve national cybersecurity. He is also Certified as an Information Systems Security Professional (CISSP).
Melanie Rivers is Senior Vice President, Chief Human Resources Officer at Accuray, with responsibility for leading global HR operations, including compensation, benefits, learning and development, and communications directed at building a strong, engaged team. Additionally, she is the primary executive in charge of guiding the advancement and adoption of the organization’s Diversity & Inclusion initiatives. Melanie joined Accuray in 2021 as Vice President Global Human Resources and was promoted to her current position in 2024.
Melanie has a proven track record of aligning human capital strategies with business goals to deliver results through improved performance, engagement, profitability and growth. Prior to joining Accuray, Melanie spent nearly four years as the Global Senior Human Resources Director at Genus Plc where she provided strategic support to the R&D and IntelliGen Technologies business and its nine manufacturing labs and research labs, across the globe including India, UK, Brazil, and the U.S. Previously, she was with Amcor Ltd for over seven years in various HR leadership roles of increasing responsibility including her last position, as Director, where she led a team through post-merger integration work involving six manufacturing sites and the corporate headquarters.
Melanie holds bachelor’s degrees in both political science and German language, literature & culture from the University of Wisconsin – Madison, and is a Senior Certified Professional by the Society for Human Resources Management. She speaks fluent German and has dual citizenship with Germany.
“What excites me most about my role is the opportunity to lead such a remarkably passionate and intelligent team. I love focusing that passionate intellect into creating and supporting products that demonstrate our values to our customers. Earning the trust of the clinical teams who use radiotherapy systems is the spark that first got me into the medical device field and Accuray is the place where I continue to be motivated every day by our customers who have placed their confidence in our people and our products.”
Mu Young Lee rejoined Accuray in September 2023 as Senior Vice President, Research and Product Development. In this role, he is responsible for strategic leadership and execution of the company’s technology vision, helping to drive the development of innovative new products aligned with the needs of our customers.
Mu has worked at universities and defense contractors, entering the medical device field in 2006 when he joined Accuray for his first stint at the company. His experience in the radiotherapy industry has spanned roles in R&D, product management, UX, product marketing, and project portfolio management. Mu has led major development programs in capital medical equipment such as designing and launching a radiotherapy treatment system that generated >$1B in business within 5 years of product unveiling. On the software front, he has led SaaS-transformation initiatives to develop web-based software medical devices for radiation oncology and neurovascular use cases.
Mu earned a Ph.D. in nuclear physics from the University of Michigan and undergraduate degree in physics from Yale University in New Haven, Connecticut.
“Working for more than 20 years in MedTech, my purpose has remained clear – to help bring hope, dignity and the highest possible quality of life to those facing a life-changing diagnosis. Cancer in particular is an incredibly complex disease to treat and like so many, I’ve seen first-hand the profound and often unexpected impact it has on patients and their loved ones.
Working at Accuray, I have the privilege to work passionately alongside exceptional, forward-thinking colleagues and partners who share a deep commitment to continuously advancing radiation therapy. Together, we focus on innovation that’s not only sophisticated, but that is truly patient-centered, delivering treatments that are personalized, precise and safe – to achieve best possible outcomes for every patient.”
Johannes Høgseth-Diebold is President and General Manager of the Asia Pacific (APAC) region, bringing with him more than 20 years of global experience in the MedTech industry. In this role he is responsible for driving the region’s strategic direction and operational goals, helping advance cancer care across APAC. His responsibilities include business development, sales and marketing management, service and the P&L for the region.
Prior to joining Accuray, Johannes held several senior leadership positions at Varian Medical Systems, a Siemens Healthineers company. His responsibilities spanned both the Varian Oncology and the Varian Proton businesses, across Europe, Middle East, Africa (EMEA) and Asia Pacific, Japan and India (APJI) with a focus on sales, service and business development.
Before Varian, Johannes held management positions at Nihon Kohden, a leading manufacturer of medical electronics and Dräger Medical, a global leader in the fields of medical and safety technology.
Johannes earned his MA of Business Administration degree from the University of Applied Sciences in Esslingen/Neckar Germany and has spent the last two decades living in Europe, Middle East and Asia.
“Throughout my career it has been my personal goal to be involved in helping to improve the lives of people diagnosed with serious medical conditions. I joined Accuray more than 15 years ago and I’m passionate about our unrelenting focus on developing innovative products that truly make a difference in patients’ lives.“
Xavier de Misouard is President and General Manager of the EIMEA (Europe, India, Middle East & Africa) region at Accuray. In this role he is responsible for achieving business objectives and increasing market share in the region. Xavier leads the cross-functional Accuray team and distributor commercial network, ensuring their performance aligns with the success of the region.
Xavier brings more than 30 years of global medtech experience with a demonstrated track record of operational excellence in capital equipment. He joined Accuray in 2006 as Director of Operations, Europe to launch the EIMEA operations and was subsequently promoted to VP EIMEA & International Operations, before taking on his current role. Prior to joining Accuray, Xavier was employed for 18 years at Siemens Medical Solutions (now Siemens Healthineers) in various roles of increasing responsibility, both in France and in the U.S.
Xavier earned a Master’s degree in Technology, Management & Finance from the University of Caen.
“I am passionate about partnering with our amazing team to relieve the suffering of cancer patients caused by their disease. Our innovative products and solutions provide an accurate and effective treatment option that can truly improve patients’ lives.”
Kazuharu Tomari is President and General Manager of the Japan region at Accuray with responsibility for the customer-facing functional team and region P&L. He joined Accuray in 2011 as Regional Business Director for Japan and was subsequently promoted to Senior Director National Sales for Japan in 2016 before taking on his current position in 2024.
Kazuharu has over 25 years of medical device and business experience with particular expertise in sales and sales leadership. During his tenure with Accuray, Kazuharu generated the highest number of annual orders in the company’s history, exceeded annual growth targets and expanded sales channels, significantly contributing to the region’s growth. Prior to joining Accuray, he worked for LIXIL Corporation, an industrial products manufacturer, and LifeScan, a division of Johnson & Johnson.
Kazuharu earned a Bachelor’s degree in Economics from Kobe University, in Hyogo, Japan.
“Cancer will impact everyone directly or indirectly at some point in their lives. I’m excited to be working at a company with an incredible purpose and the ability to positively impact the lives of their customers and patients.”
Nancy Hiller is President and General Manager for the Americas (North and South America) region at Accuray. In this role, Nancy is responsible for the commercial and service strategy with a focus on growing the customer install base and expanding the service and solutions business through exceptional customer service and operational excellence.
Nancy joins Accuray with nearly 25 years of healthcare experience spanning imaging and capital equipment, AI, revenue cycle, digital and workflow management. Prior to joining Accuray, Nancy spent 14 years at GE Healthcare where she most recently led the US and Canadian x-ray commercial teams. Before GE Healthcare, Nancy worked as a practice manager and revenue cycle director for private practices involved in anesthesiology, pathology, radiation oncology and pain management.
Nancy is an inclusive leader with the ability to build trust, inspire culture and drive results. She brings a demonstrated history of proven success in sales, marketing and business management highlighted by a keen sense of interpersonal dynamics that foster strong personal relationships with clients and colleagues.
Nancy holds a Master of Business Administration degree from the University of Phoenix and a bachelor’s degree in communications from the University of Montana in Missoula, Montana.
Yi Zhongwei (LaoYi) is CEO of the CNNC-Accuray joint venture and is also responsible for the China region. LaoYi brings more than 25 years of experience in the China healthcare industry and has held senior executive roles across a range of sectors including imaging, radiation, nuclear medicine, interventional, urology and gynecology. LaoYi’s background includes over seven years as General Manager with Lumenis China and more than 21 years at GE Healthcare China, including four years as General Manager of GE Healthcare service sales from 2012 to 2016. During this timeframe he drove significant revenue growth, increasing it from $200M to $300M in just three years, double the growth rate vs the market.
LaoYi earned a Master of Business Administration degree from the China Europe International Business School and a Bachelor’s degree in automation engineer technology/technician from Beijing Institute of Technology.
Serviço líder do setor para apoiar seu sucesso contínuo, desde instalação e otimização rápidas, monitoramento proativo e serviço no local incomparável, até caminhos de atualização inteligentes para manter seu sistema na vanguarda.
Saiba como as tecnologias de radiação Accuray permitem que os médicos façam com que os pacientes voltem a viver suas vidas mais rapidamente. Explore as próximas inovações que abrem possibilidades inteiramente novas.
